|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 61.83 USD | +3.14% |
|
+2.52% | +4.04% |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 24.85x | - | 2.71x | 3.17x | 16.29x | 16.02x | -.--% | 1.15TCr | ||
| 20.1x | 2.38x | -4.17x | 4.65x | 13.17x | 14.26x | 0.49% | 8.14TCr | ||
| 45.43x | 5.01x | 4.04x | 7.13x | 22.55x | 30.86x | 0.5% | 6.37TCr | ||
| 51.52x | 6.93x | 1.23x | 13.6x | 29.17x | 36.53x | -.--% | 5.48TCr | ||
| 37.36x | 2.66x | -0.7x | 3.83x | 11.07x | 12.58x | 2.73% | 5.16TCr | ||
| 16.48x | 1.41x | 0.47x | 3.04x | 8.85x | 9.79x | -.--% | 2.87TCr | ||
| 15.9x | 2.74x | -21.34x | 2.61x | 8.26x | 7.76x | -.--% | 2.01TCr | ||
| 80.68x | 7.88x | -0.05x | 9.49x | 99.16x | 93.54x | -.--% | 1.98TCr | ||
| -5.57x | 2x | 0.37x | 6.56x | -3.94x | -3.74x | -.--% | 1.72TCr | ||
| 691.31x | 3.57x | -7.3x | 5.37x | 13.73x | 43.31x | -.--% | 1.58TCr | ||
| -22.05x | -7.2x | -1.13x | 31.83x | -31.88x | -31.46x | -.--% | 1.46TCr | ||
| 291.45x | 57.47x | 22.95x | 97.86x | 178.17x | 184.28x | - | 1.41TCr | ||
| -16.27x | - | -0.3x | 585.56x | -15.96x | -16.18x | -.--% | 1.1TCr | ||
| -48.44x | 200.91x | 1.32x | 14.32x | -57.58x | -53.34x | -.--% | 924.06Cr | ||
| 37.22x | - | 2.85x | 13.95x | 31.08x | 30.95x | -.--% | 834.66Cr | ||
| 18.1x | 1.21x | 0.11x | 2.08x | 8.66x | 11.5x | 1.43% | 808.54Cr | ||
| 5.33x | 2.07x | 0.01x | 2.3x | 3.42x | 3.47x | 3.8% | 754.86Cr | ||
| -222.12x | - | 0.68x | - | - | - | -.--% | 735.16Cr | ||
| 20.8x | 1.23x | -2.29x | - | - | - | 1.28% | 596.67Cr | ||
| -7.85x | 1.4x | 0.02x | 3.86x | -25.79x | -26.28x | -.--% | 585.7Cr | ||
| Average | 51.71x | 18.23x | -0.02x | 45.07x | 17.14x | 20.21x | 0.54% | 2.28TCr | |
| Weighted average by Cap. | 54.46x | 9.50x | -0.46x | 24.63x | 20.18x | 23.83x | 0.59% |
- Stock Market
- Equities
- BMRN Stock
- Sector BioMarin Pharmaceutical Inc.
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















